Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Nasopharyngeal Carcinoma × MK 2206 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 12 Neoplasms 5 Ovarian Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Carcinoma, Hepatocellular 3 Triple Negative Breast Neoplasms 2 Stomach Neoplasms 2 Rectal Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Leukemia, Myeloid, Acute 2 Gallbladder Neoplasms 2 Fallopian Tube Neoplasms 2 Colonic Neoplasms 2 Breast Neoplasms, Male 2 Waldenstrom Macroglobulinemia 1 Thymoma 1 Solid Tumors 1 Small Cell Lung Carcinoma 1 Sezary Syndrome 1 Salivary Gland Neoplasms 1 Recurrent Squamous Cell Carcinoma of the Nasopharynx 1 Recurrence 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pdgfra-Associated Chronic Eosinophilic Leukemia 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Neuroendocrine Tumors 1 Nasopharyngeal Carcinoma 1 Myeloproliferative Syndrome, Transient 1

Interventions

Cisplatin 117 Gemcitabine 66 Radiotherapy, Intensity-Modulated 53 toripalimab 34 Capecitabine 34 Fluorouracil 32 Docetaxel 32 Radiotherapy 21 camrelizumab 19 Drug Therapy 19 nimotuzumab 18 spartalizumab 12 pembrolizumab 12 nedaplatin 12 apatinib 11 Induction Chemotherapy 10 tislelizumab 9 sintilimab 9 Magnetic Resonance Spectroscopy 9 Chemoradiotherapy 9 Carboplatin 9 Specimen Handling 8 Nivolumab 8 Cetuximab 8 Bevacizumab 8 endostar protein 7 Paclitaxel 7 Immune Checkpoint Inhibitors 7 Endostatins 7 fludarabine 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01370070 2017-01-13

MC1079

Chinese University of Hong Kong

Phase 2 Completed

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡